Endexx to Develop Consumable CBD Products

Endexx Engages Todd Zarlengo to Act as Co-Developer of CBD and Medical Marijuana Consumable Division

CAVE CREEK, AZ--(Marketwired - Apr 9, 2014) - Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions, announces a collaboration agreement with Todd Zarlengo, a leading Italian dessert chef and entrepreneur, to develop the manufacturing, packaging and labeling protocols for the successful launch of Endexx's new medical marijuana consumable division. The new division will focus on edible delivery systems for medical applications of cannabidiol extracts in the form of CBD-infused "cannsumer" goods for the rapidly growing $1.5 billion U.S. medical marijuana market.

Todd Zarlengo stated: "Like my father Tom, I have dedicated my life to the art of hand-made, artisanal ice cream, Italian ice, gelato and sorbet. Our family has been in the business of wholesaling and retailing frozen desserts for 31 years and I am overjoyed to bring my expertise in manufacturing premium quality frozen desserts to Endexx. We are excited to introduce the first product line of our all-new 'Cannsumer Goods' division. The debut of our new and exciting line of 'Cannsumable' products will feature all natural, CBD-infused liquid and frozen desserts. The line combines the medicinal properties of CBD in an assortment of fruit flavors that are absolutely delicious."

Todd Davis, Chairman and CEO of Endexx, said, "Mr. Zarlengo brings expertise and passion to our new Cannsumable product line. He will collaborate in all aspects of the success of this new division and unique product line. His experience in freezable and frozen products immediately positions Endexx for market leadership in CBD-infused edible products for use by patients and consumers seeking alternative therapeutic support. In addition, Mr. Zarlengo's experience in wholesaling and retailing will be crucial in building a profitable enterprise from its inception."

Cannabidiol (CBD) is a non-psychoactive natural compound that has been shown in scientific and clinical studies to possess beneficial properties in the treatment of a wide range of conditions, including arthritis, diabetes, MS, PTSD, skin cancer, epilepsy and other disorders. As mounting scientific evidence proves the efficacy of CBD in treating a wide variety of debilitating conditions, traditionally conservative states that have not supported legalization of medical marijuana are introducing legislation to legalize the use of CBD in treating medical conditions. In the last 30 days, Alabama, Georgia, Tennessee, Kentucky, Indiana, Wisconsin, Utah and Florida all have introduced or passed bills to legalize the use of CBD in the treatment of epilepsy and other debilitating conditions. Recent media coverage around the use a strain of cannabis called "Charlotte's Web," popular for its high CBD count and used to treat seizure-related disorders, has raised the profile of CBD's benefits.

About Endexx :

www.endexx.com www.gsgsolar.com www.m3hub.com www.autospense.com

Endexx Corporation collaborates with independent software engineers and architects, scientists, engineers, and other innovators to build businesses that can thrive collectively in the equity markets. The Endexx team recognizes that individually, development stage technology companies face extreme difficulty surviving as independent organizations. Through its collaborative practices, individual and group skill sets are synergistically applied to develop unique technologies and grow the businesses, while centralizing costs and eliminating redundancies. Endexx provides a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each entrepreneur is an Endexx shareholder, incentivized to contribute to the overall objective of increasing shareholder value. Endexx's management team and its advisory group each have a minimum of 10-50 years of experience in their field of expertise. The parent company's management has extensive experience growing businesses, developing and implementing new technologies and running publicly traded corporations.

Contact Endexx via email to receive corporate news and updates at Endexx@endexx.com.

http://www.otcmarkets.com/stock/EDXC/quote

Safe Harbor Notice: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Endexx Corporation Todd Davis Chairman & CEO endexx@endexx.com M3Hub Sales: 480-999-0097 Investor Relations IRTH Communications Andrew Haag Managing Partner EDXC@irthcommunications.com 866-976-4784

Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From Mar 2024 to Apr 2024